Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-005682

Chief Administrative Officer acquired 24,170 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Porter Andy Chief Administrative Officer 2022-01-27 Grant or award +24,170 47,317 D
Derivatives
Porter Andy Chief Administrative Officer 2022-01-27 Grant or award · Stock Option (Right to Buy) +48,340 48,340 D
Loading xslF345X03/doc4.xml…